Published on 10/10/2012
Regularly taking aspirin may reduce your risk of developing an aggressive form of ovarian cancer, according to a new Danish study.
Ovarian cancer is the fifth leading cause of death from cancer among women living in developed countries, and has been named as the deadliest gynaecological malignancy.
Scientists at the Danish Cancer Society Research Centre looked at data on 756 Danish women collected from MALOVA, a malignant ovarian cancer study.
All of the participants were diagnosed with epithelial ovarian cancer between 1995 and 1999. 447 of these had serous ovarian cancer, an aggressive form that affects the surface of the ovary. 138 had mucinous disease, and 171 had other types.
The researchers compared with women’s use of painkillers with that of 1,564 randomly selected women who did not have ovarian cancer.
Writing in the journal Acta Obstetricia et Gynecologica Scandinavica, they found that women who regularly used aspirin were less likely to develop serous ovarian cancer than those who did not.
Other anti-inflammatory drugs and paracetamol were not associated with a reduced risk.
Lead study author Dr Susanne Kjaer said: 'Understanding what factors are involved in the development of this disease and investigating preventative interventions for women are vitally important.
'Our findings suggest a potential protective effect of analgesic use on ovarian cancer risk, but that benefit should be balanced against adverse effects of pain medication use, such as risk of bleeding and peptic ulcers.'
If you want to guarantee the best private ovarian cancer treatment that the UK has to offer, compare health insurance quotes with full cancer cover.
© ActiveQuote Ltd. 2012Categories: Medical